Follicular lymphoma grade I, intrathoracic lymph nodes
ICD-10 C82.02 is a billable code used to indicate a diagnosis of follicular lymphoma grade i, intrathoracic lymph nodes.
Follicular lymphoma is a type of non-Hodgkin lymphoma characterized by the proliferation of follicle center (germinal center) B-cells. Grade I indicates a low-grade lymphoma with a relatively indolent course. When this lymphoma affects the intrathoracic lymph nodes, it typically presents with a slow-growing mass that may be asymptomatic or associated with B-symptoms such as fever, night sweats, and weight loss. Diagnosis is often confirmed through lymph node biopsy, which reveals the characteristic follicular architecture. Staging is crucial, as it determines the extent of disease and guides treatment. The Ann Arbor staging system is commonly used, with stages I and II indicating localized disease and stages III and IV indicating more advanced disease. Treatment options may include watchful waiting for asymptomatic patients, chemotherapy, immunotherapy, or radiation therapy, depending on the stage and symptoms. Regular follow-up is essential to monitor for disease progression or transformation to a more aggressive form of lymphoma.
Detailed clinical notes on symptoms, staging, and treatment plans.
Patients presenting with lymphadenopathy, B-symptoms, or incidental findings on imaging.
Accurate documentation of treatment response and any changes in disease status.
Comprehensive biopsy reports detailing histological findings.
Biopsy of lymph nodes showing follicular architecture.
Clear differentiation between grades and types of lymphoma in pathology reports.
Used when a biopsy is performed to confirm diagnosis.
Pathology report must detail findings and confirm diagnosis.
Pathologists must ensure accurate grading and staging in reports.
Common treatments include watchful waiting for asymptomatic patients, chemotherapy, immunotherapy, and radiation therapy, depending on the stage and symptoms.
